Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

9.47
Delayed Data
As of 1:05pm ET
 -0.0892 / -0.93%
Today’s Change
8.88
Today|||52-Week Range
13.67
-22.62%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close9.56
Today’s open9.56
Day’s range9.46 - 9.64
Volume73,786
Average volume (3 months)435,321
Market cap$522.6M
Dividend yield--
Data as of 1:05pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-15.00%
Earnings growth (this year)+7.58%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+25.03%
P/E ratioNM
Price/Sales10.95
Price/Book11.67

Competitors

 Today’s
change
Today’s
% change
TCMDTactile Systems Tech...-2.18-6.42%
ATRSAntares Pharma Inc+0.05+1.88%
ANGOAngioDynamics Inc+0.09+0.50%
LMATLeMaitre Vascular In...-0.12-0.32%
Data as of 1:24pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$49.3M
Annual profit (last year)-$50.6M
Net profit margin-102.69%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
CFO &
Principal Accounting Office
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts